» Articles » PMID: 34505197

Fibroepithelial Tumours of the Breast-a Review

Overview
Journal Virchows Arch
Date 2021 Sep 10
PMID 34505197
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Fibroepithelial tumours of the breast are biphasic neoplasms composed of both epithelial and stromal elements, including the common fibroadenoma and the infrequent phyllodes tumour. The admixture of epithelium and stroma in the fibroadenoma shows intra- and pericanalicular patterns, and may display a variety of histological changes. Fibroadenoma variants include the cellular, juvenile, myxoid and complex forms. The cellular fibroadenoma may be difficult to distinguish from the benign phyllodes tumour. Stromal mitotic activity can be increased in fibroadenomas in the young and pregnant patients. Phyllodes tumours, neoplasms with the potential for recurrence, show an exaggerated intracanalicular growth pattern with broad stromal fronded architecture and stromal hypercellularity. They are graded into benign, borderline and malignant forms based on histological assessment of stromal features of hypercellularity, atypia, mitotic activity, overgrowth and the nature of the tumour borders. Classification of phyllodes tumours is imperfect, compounded by tumour heterogeneity with overlapping microscopic features among the different grades, especially in the borderline category. Malignant phyllodes tumours can metastasise and cause death. Determining which phyllodes tumours may behave aggressively has been difficult. The discovery of MED12 mutations in the pathogenesis of fibroepithelial tumours, together with other gene abnormalities in the progression pathway, has allowed refinements in diagnosis and prognosis.

Citing Articles

Benign phyllodes tumor of the distal end of the ureter: an extremely rare case and literature review.

Xu L, Song P, Pin J BMC Urol. 2024; 24(1):267.

PMID: 39702215 PMC: 11656880. DOI: 10.1186/s12894-024-01665-8.


Clinical values of nuclear morphometric analysis in fibroepithelial lesions.

Lee C, Yip H, Li J, Ng J, Tsang J, Loong T Breast Cancer Res. 2024; 26(1):156.

PMID: 39529160 PMC: 11552124. DOI: 10.1186/s13058-024-01912-8.


Breast tumor with giant borderline phyllodes: Case report and literature review.

Zhang G, Zeng J, Li C, Wei C Medicine (Baltimore). 2024; 103(44):e37260.

PMID: 39496019 PMC: 11537575. DOI: 10.1097/MD.0000000000037260.


Breast carcinoma arising in a fibroadenoma: A case series of 16 patients and review of the literature.

Xu L, Luo S, Mao Q, Gao Y, Luo L, Qu W Oncol Lett. 2023; 27(1):39.

PMID: 38116580 PMC: 10728692. DOI: 10.3892/ol.2023.14172.


Efficacy and safety of vacuum-assisted excision (VAE) of fibroadenomas: experience in a tertiary centre.

Carriero S, Depretto C, Cozzi A, Della Pepa G, DAscoli E, Irmici G Radiol Med. 2023; 128(10):1199-1205.

PMID: 37530965 PMC: 10547646. DOI: 10.1007/s11547-023-01684-9.


References
1.
Shin S, Rosen P . Bilateral presentation of fibroadenoma with digital fibroma-like inclusions in the male breast. Arch Pathol Lab Med. 2007; 131(7):1126-9. DOI: 10.5858/2007-131-1126-BPOFWD. View

2.
Pike A, OBERMAN H . Juvenile (cellular) adenofibromas. A clinicopathologic study. Am J Surg Pathol. 1985; 9(10):730-6. DOI: 10.1097/00000478-198510000-00004. View

3.
Nassar A, Visscher D, Degnim A, Frank R, Vierkant R, Frost M . Complex fibroadenoma and breast cancer risk: a Mayo Clinic Benign Breast Disease Cohort Study. Breast Cancer Res Treat. 2015; 153(2):397-405. PMC: 4561026. DOI: 10.1007/s10549-015-3535-8. View

4.
Carney J, Toorkey B . Myxoid fibroadenoma and allied conditions (myxomatosis) of the breast. A heritable disorder with special associations including cardiac and cutaneous myxomas. Am J Surg Pathol. 1991; 15(8):713-21. DOI: 10.1097/00000478-199108000-00001. View

5.
Lozada J, Burke K, Maguire A, Pareja F, Lim R, Kim J . Myxoid fibroadenomas differ from conventional fibroadenomas: a hypothesis-generating study. Histopathology. 2017; 71(4):626-634. PMC: 5597459. DOI: 10.1111/his.13258. View